Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Bank & private debt | 1 | 33% |
| Other / undisclosed | 1 | 33% |
US-based dermatology-focused specialty pharma, acquired by Peplin
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Bank & private debt | 1 | 33% |
| Other / undisclosed | 1 | 33% |